← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2001Last known activity
Sep 1, 2020
Timeline
2000s
- Jun 1, 2001
Vancouver Coastal Health— Founded
Drugs by trial phase (24 distinct, 20 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Atrial Fibrillation
- Autonomic Dysreflexia
- Breast Diseases
- Breast Neoplasms
- Carcinoid Tumor
- Chronic Pain
- Communicable Diseases
- Coronavirus Infections
- Critical Illness
- Emergencies
- Gender Dysphoria
- Heart Arrest
- Infections
- Keratosis
- Keratosis, Actinic
- Neoplasms
- Neoplasms by Site
- Neuroblastoma
- Paraganglioma
- Pheochromocytoma
- Severe Acute Respiratory Syndrome
- Skin Diseases
- Spinal Cord Injuries
- Substance-Related Disorders
- Thromboembolism
- Thrombosis
- Thyroid Neoplasms
- Urinary Bladder Neoplasms
- Venous Thrombosis
- Virus Diseases
Recent trials (25)
- NCT04139655CollaboratorN/ASep 1, 2020
- NCT04337918Overall official - principal investigatorPhase 2Apr 6, 2020
- NCT04234191CollaboratorPhase 2Feb 29, 2020
- NCT03179475CollaboratorPhase 3Jun 15, 2017
- NCT02676154CollaboratorPhase 2Feb 1, 2016
- NCT02229617CollaboratorPhase 1/Phase 2Jul 1, 2015
- NCT02280239CollaboratorPhase 4May 1, 2015
- NCT02280239Overall official - principal investigatorPhase 4May 1, 2015
- NCT02376803CollaboratorPhase 4Feb 1, 2015
- NCT01427400CollaboratorPhase 4Oct 1, 2011
- NCT01123122Lead sponsorN/ASep 30, 2011
- NCT01373736Overall official - principal investigatorPhase 3Jun 13, 2011
- NCT01373736Lead sponsorPhase 3Jun 13, 2011
- NCT01211158CollaboratorPhase 3Dec 1, 2010
- NCT01158898Overall official - principal investigatorPhase 2Nov 1, 2010
Details
- Founded
- Vancouver, VU Jun 1, 2001
- Last known activity
- Sep 1, 2020